ClinicalTrials.Veeva

Menu

Post-Operative Treatment With Ketorolac After Abdominal Myomectomy

A

Ascher-Walsh, Charles, M.D.

Status

Completed

Conditions

Febrile Morbidity
Pain

Treatments

Drug: ketorolac
Drug: saline

Study type

Interventional

Funder types

Other

Identifiers

NCT00845754
ASW 124

Details and patient eligibility

About

The purpose of this study is to determine if ketorolac, given after abdominal myomectomy, will decrease the frequency of post-oerative fevers as well as improve post-operative pain management.

Enrollment

112 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ant patient undregoing abdominal myomectomy

Exclusion criteria

  • Patients with contraindication to NSAIDs including history of peptic ulcer disease, renal disease, bleeding diathesis, or hypersensitivity to NSAIDS

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

112 participants in 2 patient groups, including a placebo group

1
Placebo Comparator group
Description:
Placebo
Treatment:
Drug: saline
2
Active Comparator group
Description:
Ketorolac
Treatment:
Drug: ketorolac

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems